Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A multilevel research perspective on cancer care delivery: the example of follow-up to an abnormal mammogram.

Taplin SH, Yabroff KR, Zapka J.

Cancer Epidemiol Biomarkers Prev. 2012 Oct;21(10):1709-15. doi: 10.1158/1055-9965.EPI-12-0265. Epub 2012 Aug 21.

2.

Factors in quality care--the case of follow-up to abnormal cancer screening tests--problems in the steps and interfaces of care.

Zapka J, Taplin SH, Price RA, Cranos C, Yabroff R.

J Natl Cancer Inst Monogr. 2010;2010(40):58-71. doi: 10.1093/jncimonographs/lgq009. Review.

3.

Follow-up to abnormal cancer screening tests: considering the multilevel context of care.

Zapka JM, Edwards HM, Chollette V, Taplin SH.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1965-73. doi: 10.1158/1055-9965.EPI-14-0454. Epub 2014 Jul 29. Review.

4.
5.

Evaluation of abnormal mammography results and palpable breast abnormalities.

Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D.

Ann Intern Med. 2003 Aug 19;139(4):274-84. Review.

PMID:
12965983
6.

Measuring integrated care.

Strandberg-Larsen M.

Dan Med Bull. 2011 Feb;58(2):B4245. Review.

PMID:
21299927
7.

Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases.

Rivas AL, Leitner G, Jankowski MD, Hoogesteijn AL, Iandiorio MJ, Chatzipanagiotou S, Ioannidis A, Blum SE, Piccinini R, Antoniades A, Fazio JC, Apidianakis Y, Fair JM, Van Regenmortel MHV.

Front Immunol. 2017 May 31;8:612. doi: 10.3389/fimmu.2017.00612. eCollection 2017. Review.

Supplemental Content

Support Center